Regeneron Pharmaceuticals (REGN)

Of the undervalued stocks that Goldman Sachs recently thrust into the spotlight, these three are the most promising stocks to buy. Here's what you need to know about each.

7 Big Biotech Stocks to Watch

By Chris Lau, InvestorPlace Contributor Sep 27, 2019

Biotech stocks are still out of favor because of macro uncertainties. But beneath that, investors may find companies trading at deep value.

Compare Brokers

3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector

By Louis Navellier, Editor, Growth Investor Sep 14, 2019

When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).

8 Biotech Stocks to Watch After the Q2 Earnings Season

By Chris Lau, InvestorPlace Contributor Aug 20, 2019

Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.

4 Biotech Stocks Sliding Lower

By William Roth, InvestorPlace Market Strategist Jul 26, 2019

Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.

Nasdaq Today: Biotech Wrecked; Buy Microsoft?

By Bret Kenwell, InvestorPlace Contributor Jul 11, 2019

Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.

Nasdaq Today: Semis Rally, Micron Earnings, Suing FB and GOOGL?

By Bret Kenwell, InvestorPlace Contributor Jun 26, 2019

Trump says that Facebook and Alphabet should be sued, while Micron surged on earnings. Semiconductors got a big boost in the Nasdaq today as well.

5 Growthy Biotech Stocks to Buy Despite the Scrutiny

By Chris Lau, InvestorPlace Contributor May 13, 2019

Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?

Compare Brokers

Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss

By William White, InvestorPlace Writer May 7, 2019

Regeneron Pharmaceuticals earnings for the first quarter of 2019 have REGN stock falling on Tuesday due to poor results for the period.

5 Biotech Stocks for a Long-Lived Portfolio

By Chris Lau, InvestorPlace Contributor Apr 30, 2019

Biotech stocks fell sharply in the last few weeks, mostly on no new news. This drop may have created an entry point for investors.

7 Companies With Unacceptable CEO-Worker Wage Gaps

By Will Ashworth, InvestorPlace Contributor Apr 24, 2019

While some companies are doing a good job closing their CEO-Worker wage gaps, these seven companies are not.

This Is Why You Shouldn’t Count Regeneron Stock Out

By Dana Blankenhorn, InvestorPlace Contributor Apr 22, 2019

When drug companies fall out of favor, as now, I look first to companies with a method for drug discovery like Regeneron stock.

7 Best Stocks to Buy Until the Next Seismic Shift

By Dana Blankenhorn, InvestorPlace Contributor Jan 23, 2019

No company can guarantee its future, but here are some that are well-positioned to take advantage of current trends.

3 of the Top Big Pharma Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor Jan 15, 2019

Big pharma stocks are getting good coverage from JPMorgan's healthcare event. Here are three undervalued pharmaceutical stocks to buy now.

Compare Brokers

Market Leadership’s Odd Couple: Wingstop and Regeneron

By Chris Tyler, InvestorPlace Contributor Jan 9, 2019

It might seem like an odd pairing, but WING and REGN stock have similar leadership qualities off and on the price chart.

The 3 Best Stocks to Buy At the End of the Bear Market

By Dana Blankenhorn, InvestorPlace Contributor Jan 4, 2019

The best stocks to buy at the bottom of a bear market are those you can see growing over the next three to five years.

Noteworthy Thursday Option Activity: REGN, XNCR, EBIX

From Market News Video Nov 14, 2019

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Regeneron Pharmaceuticals, Inc. (REGN), where a total volume of 6,805 contracts has been traded thus far today, a contract volume which is representative of approximately 680,500 underlying shares (given that every 1 contract represents 100 underlying shares)..

Thursday Sector Laggards: Consumer Products, Healthcare

From Market News Video Nov 14, 2019

The worst performing sector as of midday Thursday is the Consumer Products sector, showing a 0.2% loss. Within that group, Kraft Heinz Co (KHC) and Philip Morris International Inc (PM) are two large stocks that are lagging, showing a loss of 6.4% and 1.2%, respectively..

Yesterday, the EVP Research and Development of Regeneron (REGN – Research Report), Neil Stahl, sold shares of REGN for $2.49M. In addition to Neil Stahl, one other REGN executive reported Sell trades in the last month. See today’s analyst top recommended stocks >> Based on Regeneron’s latest earnings report for the quarter ending September 30,

7 Biotech Stocks to Buy With Plenty of Power in the Pipeline

From InvestorPlace Nov 12, 2019

With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.

Navellier Ratings

Total Grade

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

Regeneron Pharmaceuticals (REGN)

Navellier Ratings

Total Grade

10 Stocks Set for Monster Growth

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

Regeneron Pharmaceuticals (REGN)

REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News

Navellier Ratings

Total Grade

10 Stocks Set for Monster Growth

Subscriber Sign in